{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:00:41Z","timestamp":1793448041520,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18342-x","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:27:33Z","timestamp":1769513253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors determining survival in oligometastatic breast cancer in a retrospective cohort study from a low and middle income country"],"prefix":"10.1038","volume":"16","author":[{"given":"Kulsoom","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Uzair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna Mushtaq","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakina","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"18342_CR1","unstructured":"CDC. Metastatic Female Breast Cancer Incidence. https:\/\/www.cdc.gov\/united-states-cancer-statistics\/publications\/metastatic-breast-cancer.html#cdc_research_or_data_summary_res_data-trends-in-metastatic-female-breast-cancer-incidence-by-race-and-ethnicity."},{"key":"18342_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"18342_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","volume":"10","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Global trends and forecasts of breast cancer incidence and deaths. Sci. Data 10, 334 (2023).","journal-title":"Sci. Data"},{"key":"18342_CR4","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.18632\/oncotarget.3455","volume":"6","author":"DK Reyes","year":"2015","unstructured":"Reyes, D. K., Pienta, K. J., Reyes, D. K. & Pienta, K. J. The biology and treatment of oligometastatic cancer. Oncotarget 6, 8491\u20138524 (2015).","journal-title":"Oncotarget"},{"key":"18342_CR5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","volume":"32","author":"A Gennari","year":"2021","unstructured":"Gennari, A. et al. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann. Oncol. 32, 1475\u20131495 (2021).","journal-title":"Ann. Oncol."},{"key":"18342_CR6","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1200\/JCO.1994.12.10.2229","volume":"12","author":"S Hellman","year":"1994","unstructured":"Hellman, S. Natural history of small breast cancers. J. Clin. Oncol. 12, 2229\u20132234 (1994).","journal-title":"J. Clin. Oncol."},{"key":"18342_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","volume":"8","author":"RR Weichselbaum","year":"2011","unstructured":"Weichselbaum, R. R. & Hellman, S. Oligometastases revisited. Nat. Rev. Clin. Oncol. 8, 378\u2013382 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"18342_CR8","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer, E. et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob. Health 8, e1027\u2013e1037 (2020).","journal-title":"Lancet Glob. Health"},{"key":"18342_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/PPO.0000000000000439","volume":"26","author":"N Hafez","year":"2020","unstructured":"Hafez, N. & Gettinger, S. Oligometastatic disease and local therapies: A medical oncology perspective. Cancer J. 26, 144\u2013148 (2020).","journal-title":"Cancer J."},{"key":"18342_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000358750","volume":"9","author":"S Di Lascio","year":"2014","unstructured":"Di Lascio, S. & Pagani, O. Oligometastatic breast cancer: A shift from palliative to potentially curative treatment?. Breast Care 9, 7\u201314 (2014).","journal-title":"Breast Care"},{"key":"18342_CR11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","volume":"31","author":"F Cardoso","year":"2020","unstructured":"Cardoso, F. et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann. Oncol. 31, 1623\u20131649 (2020).","journal-title":"Ann. Oncol."},{"key":"18342_CR12","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1245\/s10434-012-2333-3","volume":"19","author":"DHA Nguyen","year":"2012","unstructured":"Nguyen, D. H. A. et al. Limited M1 disease: A significant prognostic factor for stage IV breast cancer. Ann. Surg. Oncol. 19, 3028\u20133034 (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"18342_CR13","doi-asserted-by":"publisher","first-page":"pkab010","DOI":"10.1093\/jncics\/pkab010","volume":"5","author":"TG Steenbruggen","year":"2021","unstructured":"Steenbruggen, T. G. et al. Characterization of oligometastatic disease in a real-world nationwide cohort of 3447 patients with de novo metastatic breast cancer. JNCI Cancer Spectr. 5, pkab010 (2021).","journal-title":"JNCI Cancer Spectr."},{"key":"18342_CR14","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/ijc.33152","volume":"147","author":"B Lan","year":"2020","unstructured":"Lan, B. et al. Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China. Int. J. Cancer 147, 3199\u20133205 (2020).","journal-title":"Int. J. Cancer"},{"key":"18342_CR15","first-page":"1441","volume":"7","author":"J Fan","year":"2015","unstructured":"Fan, J., Chen, D., Du, H., Shen, C. & Che, G. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: A systematic review and meta-analysis. J. Thorac. Dis. 7, 1441 (2015).","journal-title":"J. Thorac. Dis."},{"key":"18342_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cncr.11881","volume":"100","author":"D Planchard","year":"2004","unstructured":"Planchard, D. et al. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer 100, 28\u201335 (2004).","journal-title":"Cancer"},{"key":"18342_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1010-7940(02)00331-7","volume":"22","author":"G Friedel","year":"2002","unstructured":"Friedel, G. et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases. Eur. J. Cardiothorac. Surg. 22, 335\u2013344 (2002).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"18342_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejso.2008.05.005","volume":"35","author":"F Chen","year":"2009","unstructured":"Chen, F. et al. Clinical features of surgical resection for pulmonary metastasis from breast cancer. Eur. J. Surg. Oncol. 35, 393\u2013397 (2009).","journal-title":"Eur. J. Surg. Oncol."},{"key":"18342_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1200\/JCO.21.02006","volume":"40","author":"SA Khan","year":"2022","unstructured":"Khan, S. A. et al. Early local therapy for the primary site in de novo stage IV breast cancer: Results of a randomized clinical trial (EA2108). J. Clin. Oncol. 40, 978 (2022).","journal-title":"J. Clin. Oncol."},{"key":"18342_CR20","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1245\/s10434-018-6494-6","volume":"25","author":"A Soran","year":"2018","unstructured":"Soran, A. et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: Protocol MF07-01. Ann Surg Oncol 25, 3141\u20133149 (2018).","journal-title":"Ann Surg Oncol"},{"key":"18342_CR21","first-page":"1064","volume":"21","author":"DD Maki","year":"2000","unstructured":"Maki, D. D. & Grossman, R. I. Patterns of disease spread in metastatic breast carcinoma: Influence of estrogen and progesterone receptor status. AJNR Am. J. Neuroradiol. 21, 1064 (2000).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"18342_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5152\/ejbh.2020.080620","volume":"16","author":"A Soran","year":"2020","unstructured":"Soran, A. et al. Loco-regional treatment for intact primary tumor in patient with de novo metastatic breast cancer; Comments and concerns of ECOG-ACRIN 2108 trial. Eur. J. Breast Health 16, 158\u2013159 (2020).","journal-title":"Eur. J. Breast Health"},{"key":"18342_CR23","first-page":"1","volume":"21","author":"Z Huang","year":"2021","unstructured":"Huang, Z. et al. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: A large cohort retrospective study. BMC Cancer 21, 1\u201318 (2021).","journal-title":"BMC Cancer"},{"key":"18342_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1200\/JCO.2023.41.16_suppl.523","volume":"41","author":"T Shien","year":"2023","unstructured":"Shien, T. et al. A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017. J. Clin. Oncol. 41, 523\u2013523 (2023).","journal-title":"J. Clin. Oncol."},{"key":"18342_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.breast.2022.12.007","volume":"67","author":"A van Ommen-Nijhof","year":"2023","unstructured":"van Ommen-Nijhof, A. et al. Survival and prognostic factors in oligometastatic breast cancer. Breast 67, 14\u201320 (2023).","journal-title":"Breast"},{"key":"18342_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-75119-0","volume":"10","author":"L Ma","year":"2020","unstructured":"Ma, L. et al. Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China. Sci. Rep. 10, 1\u20138 (2020).","journal-title":"Sci. Rep."},{"key":"18342_CR27","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00670","author":"TG Steenbruggen","year":"2023","unstructured":"Steenbruggen, T. G. et al. Characterization of the tumor microenvironment of de novo oligometastatic breast cancer in a nationwide cohort. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/PO.22.00670 (2023).","journal-title":"JCO Precis. Oncol."},{"key":"18342_CR28","doi-asserted-by":"publisher","first-page":"102114","DOI":"10.1016\/j.ctrv.2020.102114","volume":"91","author":"A van Ommen-Nijhof","year":"2020","unstructured":"van Ommen-Nijhof, A. et al. Prognostic factors in patients with oligometastatic breast cancer\u2014A systematic review. Cancer Treat Rev 91, 102114 (2020).","journal-title":"Cancer Treat Rev"},{"key":"18342_CR29","first-page":"111224","volume":"27","author":"C Wu","year":"2024","unstructured":"Wu, C. et al. Primary tumor resection in de novo metastatic breast cancer from an oligometastatic perspective: A systematic review and meta-analysis. Science 27, 111224 (2024).","journal-title":"Science"},{"key":"18342_CR30","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s12282-021-01240-1","volume":"28","author":"E Nagasaki","year":"2021","unstructured":"Nagasaki, E. et al. Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: An updated report. Breast Cancer 28, 1051\u20131061 (2021).","journal-title":"Breast Cancer"},{"key":"18342_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000001129","author":"L Pujari","year":"2024","unstructured":"Pujari, L. et al. Outcomes of de novo oligometastatic breast cancer treated with surgery of primary and metastasis directed radiotherapy. Am. J. Clin. Oncol. Cancer Clin. Trials https:\/\/doi.org\/10.1097\/COC.0000000000001129 (2024).","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"key":"18342_CR32","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s11864-024-01275-4","volume":"25","author":"DN Zouki","year":"2024","unstructured":"Zouki, D. N., Karatrasoglou, E. A., Pilichos, G. & Papadimitraki, E. Oligometastatic breast cancer: Seeking the cure by redefining stage IV disease?. Curr. Treat Options Oncol. 25, 1482\u20131494 (2024).","journal-title":"Curr. Treat Options Oncol."},{"key":"18342_CR33","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/nu14122376","volume":"14","author":"Q Zuo","year":"2022","unstructured":"Zuo, Q., Park, N. H., Lee, J. K. & Erdogan, Z. M. Liver metastatic breast cancer: Epidemiology, dietary interventions, and related metabolism. Nutrients 14, 2376 (2022).","journal-title":"Nutrients"},{"key":"18342_CR34","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1245\/s10434-010-0931-5","volume":"17","author":"K Hoffmann","year":"2010","unstructured":"Hoffmann, K. et al. Liver resection for multimodal treatment of breast cancer metastases: Identification of prognostic factors. Ann. Surg. Oncol. 17, 1546\u20131554 (2010).","journal-title":"Ann. Surg. Oncol."},{"key":"18342_CR35","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1002\/cncr.25054","volume":"116","author":"HY Yhim","year":"2010","unstructured":"Yhim, H. Y. et al. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy. Cancer 116, 2890\u20132901 (2010).","journal-title":"Cancer"},{"key":"18342_CR36","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.21873\/anticanres.11601","volume":"37","author":"M Miyata","year":"2017","unstructured":"Miyata, M. et al. Salvage radiotherapy for solitary metachronous bone metastasis in patients with breast cancer. Anticancer Res. 37, 2575\u20132579 (2017).","journal-title":"Anticancer Res."},{"key":"18342_CR37","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","volume":"83","author":"MT Milano","year":"2012","unstructured":"Milano, M. T., Katz, A. W., Zhang, H. & Okunieff, P. Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study. Int. J. Radiat. Oncol. Biol. Phys. 83, 878\u2013886 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18342-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18342-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18342-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:02:01Z","timestamp":1769594521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18342-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["18342"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18342-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3674"}}